GGrantIndex
← Search

ACTG316--Nevirapine vs nevirapine placebo for the prevention of maternal fetal tr

$0M01FY2000RRNIH

La Biomed Res Inst/ Harbor Ucla Med Ctr, Torrance CA

Investigators

Linked publications & trials

Abstract

To see if a new drug called Nevirapine is effective, when given to HIV-infected women during active labor and to their babies, in reducing transmission of HIV from mother to their babies. There is a need to develop alternative and more potent antiretroviral therapies for use alone and in combination for the further reduction of perinatal transmission.

View original record on NIH RePORTER →